Utility of Sortilin as a Biomarker of Restenosis After Lower Extremity Endovascular Revascularization
NCT05759130
·
clinicaltrials.gov ↗
UNKNOWN
Status
207
Enrollment
OTHER
Sponsor class
Conditions
Peripheral Artery Disease
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS